comparemela.com

Brian Henick, MD, discusses the 3-year updated data from a phase 2 trial investigating treatment with neoadjuvant atezolizumab plus chemotherapy in patients with resectable non–small cell lung cancer.

Related Keywords

,Brian Henick ,Columbia University Herbert Irving Comprehensive Cancer Center ,Experimental Therapeutics ,Translational Research ,Aerodigestive Cancers ,Medical Oncology ,Lancet Oncology ,Lung Cancer ,Onclive Tv ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.